Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5.

Experimental and therapeutic medicine

Popa O, Taban SM, Pantea S, Plopeanu AD, Barna RA, Cornianu M, Pascu AA, Dema ALC.
PMID: 34475969
Exp Ther Med. 2021 Oct;22(4):1179. doi: 10.3892/etm.2021.10613. Epub 2021 Aug 13.

The 2019 World Health Organization (WHO) classification of gastrointestinal tumors defines well-differentiated grade 3 neuroendocrine tumors, the mixed neuroendocrine-non-neuroendocrine tumors (MiNENs) and classifies goblet cell carcinoid as goblet cell adenocarcinoma. The expression of somatostatin receptors (SSTRs) is the foundation...

Cite
Popa O, Taban SM, Pantea S, et al. The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5. Exp Ther Med. 2021;22(4):1179doi: 10.3892/etm.2021.10613.
Popa, O., Taban, S. M., Pantea, S., Plopeanu, A. D., Barna, R. A., Cornianu, M., Pascu, A. A., & Dema, A. L. C. (2021). The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5. Experimental and therapeutic medicine, 22(4), 1179. https://doi.org/10.3892/etm.2021.10613
Popa, Oana, et al. "The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5." Experimental and therapeutic medicine vol. 22,4 (2021): 1179. doi: https://doi.org/10.3892/etm.2021.10613
Popa O, Taban SM, Pantea S, Plopeanu AD, Barna RA, Cornianu M, Pascu AA, Dema ALC. The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5. Exp Ther Med. 2021 Oct;22(4):1179. doi: 10.3892/etm.2021.10613. Epub 2021 Aug 13. PMID: 34475969; PMCID: PMC8406677.
Copy Download .nbib Format: NLM
Unexpected diagnosis for a gastric polyp: Granular cell tumor: Case report and review of the literature.

Experimental and therapeutic medicine

Taban SM, Barna RA, Dema ALC, Ratiu IM, Popa O, Plopeanu AD.
PMID: 33815609
Exp Ther Med. 2021 May;21(5):536. doi: 10.3892/etm.2021.9968. Epub 2021 Mar 23.

A granular cell tumor (GCT) is a rare neoplasia that originates from Schwann cells. It usually appears in the skin or soft tissues, but it may occur anywhere in the body. The gastrointestinal tract is an unusual developmental site...

Cite
Taban SM, Barna RA, Dema ALC, et al. Unexpected diagnosis for a gastric polyp: Granular cell tumor: Case report and review of the literature. Exp Ther Med. 2021;21(5):536doi: 10.3892/etm.2021.9968.
Taban, S. M., Barna, R. A., Dema, A. L. C., Ratiu, I. M., Popa, O., & Plopeanu, A. D. (2021). Unexpected diagnosis for a gastric polyp: Granular cell tumor: Case report and review of the literature. Experimental and therapeutic medicine, 21(5), 536. https://doi.org/10.3892/etm.2021.9968
Taban, Sorina Maria, et al. "Unexpected diagnosis for a gastric polyp: Granular cell tumor: Case report and review of the literature." Experimental and therapeutic medicine vol. 21,5 (2021): 536. doi: https://doi.org/10.3892/etm.2021.9968
Taban SM, Barna RA, Dema ALC, Ratiu IM, Popa O, Plopeanu AD. Unexpected diagnosis for a gastric polyp: Granular cell tumor: Case report and review of the literature. Exp Ther Med. 2021 May;21(5):536. doi: 10.3892/etm.2021.9968. Epub 2021 Mar 23. PMID: 33815609; PMCID: PMC8014985.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries